Joseph Barbieri - Publications

Medical College of Wisconsin, Milwaukee, WI, United States 
Microbiology Biology

164 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Zuverink M, Barbieri JT. Resolving the Molecular Steps in Clostridial Neurotoxin Light Chain Translocation. Journal of Experimental Neurology. 1: 123-134. PMID 33615314 DOI: 10.33696/Neurol.1.020  0.48
2020 Zuverink M, Bluma M, Barbieri JT. Tetanus Toxin -Loop Contributes to Light-Chain Translocation. Msphere. 5. PMID 32376703 DOI: 10.1128/mSphere.00244-20  0.48
2019 Chen C, Yang C, Barbieri JT. Staphylococcal Superantigen-like protein 11 mediates neutrophil adhesion and motility arrest, a unique bacterial toxin action. Scientific Reports. 9: 4211. PMID 30862940 DOI: 10.1038/s41598-019-40817-x  0.44
2018 Chen C, Barbieri JT. Detection of ADP-Ribosylating Bacterial Toxins. Methods in Molecular Biology (Clifton, N.J.). 1813: 287-295. PMID 30097876 DOI: 10.1007/978-1-4939-8588-3_20  0.44
2018 Zuverink M, Barbieri JT. Protein Toxins That Utilize Gangliosides as Host Receptors. Progress in Molecular Biology and Translational Science. 156: 325-354. PMID 29747819 DOI: 10.1016/bs.pmbts.2017.11.010  0.48
2018 Pellett S, Bradshaw M, Tepp WH, Pier CL, Whitemarsh RCM, Chen C, Barbieri JT, Johnson EA. The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes. Mbio. 9. PMID 29588398 DOI: 10.1128/mBio.00089-18  0.44
2018 Przedpelski A, Tepp WH, Zuverink M, Johnson EA, Pellet S, Barbieri JT. Enhancing toxin-based vaccines against botulism. Vaccine. PMID 29307477 DOI: 10.1016/j.vaccine.2017.12.064  0.48
2017 Zuverink M, Barbieri JT. Protein Structure Facilitates High-resolution Immunological Mapping. Clinical and Vaccine Immunology : Cvi. PMID 29046310 DOI: 10.1128/CVI.00275-17  0.48
2017 Chen C, Barbieri JT. When Escherichia coli doesn't fit the mold: A pertussis-like toxin with altered specificity. The Journal of Biological Chemistry. 292: 15159-15160. PMID 28887436 DOI: 10.1074/jbc.H117.796094  0.44
2016 Kroken AR, Blum FC, Zuverink M, Barbieri JT. Entry of Botulinum neurotoxin subtypes A1 and A2 into neurons. Infection and Immunity. PMID 27795365 DOI: 10.1128/Iai.00795-16  0.6
2016 Barbieri JS, Riggio JM, Jaffe R. Amylase testing for abdominal pain and suspected acute pancreatitis. Journal of Hospital Medicine. 11: 366-8. PMID 27160507 DOI: 10.1002/jhm.2544  0.01
2016 Barbieri JS, Riggio JM, Jaffe R. Reducing Co-Ordering of Amylase and Lipase Testing at an Academic Medical Center: A Quality Improvement Project. American Journal of Medical Quality : the Official Journal of the American College of Medical Quality. PMID 26861763 DOI: 10.1177/1062860615620480  0.01
2016 Chen S, Barbieri JT. Solubility of the catalytic domains of Botulinum neurotoxin serotype e subtypes Protein Expression and Purification. 118: 18-24. DOI: 10.1016/j.pep.2015.10.003  1
2015 Barbieri JS, Kovarik CL. Physician spending and risk of malpractice claims: what about the effects of socioeconomic status? Bmj (Clinical Research Ed.). 351: h6765. PMID 26667649 DOI: 10.1136/bmj.h6765  0.01
2015 Zuverink M, Barbieri JT. From GFP to β-lactamase: advancing intact cell imaging for toxins and effectors. Pathogens and Disease. 73: ftv097. PMID 26500183 DOI: 10.1093/femspd/ftv097  0.48
2015 Chen C, Przedpelski A, Tepp WH, Pellett S, Johnson EA, Barbieri JT. Heat-Labile Enterotoxin IIa, a Platform To Deliver Heterologous Proteins into Neurons. Mbio. 6: e00734. PMID 26265718 DOI: 10.1128/mBio.00734-15  1
2015 Zuverink M, Chen C, Przedpelski A, Blum FC, Barbieri JT. A Heterologous Reporter Defines the Role of the Tetanus Toxin Interchain Disulfide in Light-Chain Translocation. Infection and Immunity. 83: 2714-24. PMID 25895970 DOI: 10.1128/IAI.00477-15  1
2014 Blum FC, Tepp WH, Johnson EA, Barbieri JT. Multiple domains of tetanus toxin direct entry into primary neurons. Traffic (Copenhagen, Denmark). 15: 1057-65. PMID 25040808 DOI: 10.1111/tra.12197  1
2014 Simon NC, Aktories K, Barbieri JT. Novel bacterial ADP-ribosylating toxins: structure and function. Nature Reviews. Microbiology. 12: 599-611. PMID 25023120 DOI: 10.1038/Nrmicro3310  1
2014 Barbieri JS. Basic science content in the USMLE Step 1. Jama. 311: 1358-9. PMID 24691619 DOI: 10.1001/jama.2014.1177  0.01
2014 Simon NC, Barbieri JT. Bacillus cereus Certhrax ADP-ribosylates vinculin to disrupt focal adhesion complexes and cell adhesion. The Journal of Biological Chemistry. 289: 10650-9. PMID 24573681 DOI: 10.1074/Jbc.M113.500710  1
2014 Blum FC, Przedpelski A, Tepp WH, Johnson EA, Barbieri JT. Entry of a recombinant, full-length, atoxic tetanus neurotoxin into Neuro-2a cells. Infection and Immunity. 82: 873-81. PMID 24478100 DOI: 10.1128/IAI.01539-13  1
2014 Schuld NJ, Vervacke JS, Lorimer EL, Simon NC, Hauser AD, Barbieri JT, Distefano MD, Williams CL. The chaperone protein SmgGDS interacts with small GTPases entering the prenylation pathway by recognizing the last amino acid in the CAAX motif. The Journal of Biological Chemistry. 289: 6862-76. PMID 24415755 DOI: 10.1074/Jbc.M113.527192  1
2014 Simon NC, Barbieri JT. Exoenzyme S ADP-ribosylates Rab5 effector sites to uncouple intracellular trafficking. Infection and Immunity. 82: 21-8. PMID 24101692 DOI: 10.1128/Iai.01059-13  1
2014 Blum FC, Barbieri JT. Exotoxins Reference Module in Biomedical Research. DOI: 10.1016/B978-0-12-801238-3.02396-5  1
2013 Heimer SR, Evans DJ, Stern ME, Barbieri JT, Yahr T, Fleiszig SM. Pseudomonas aeruginosa utilizes the type III secreted toxin ExoS to avoid acidified compartments within epithelial cells. Plos One. 8: e73111. PMID 24058462 DOI: 10.1371/Journal.Pone.0073111  1
2013 Przedpelski A, Tepp WH, Kroken AR, Fu Z, Kim JJ, Johnson EA, Barbieri JT. Enhancing the protective immune response against botulism. Infection and Immunity. 81: 2638-44. PMID 23670557 DOI: 10.1128/Iai.00382-13  1
2013 Silhár P, Lardy MA, Hixon MS, Shoemaker CB, Barbieri JT, Struss AK, Lively JM, Javor S, Janda KD. The C-terminus of Botulinum A Protease Has Profound and Unanticipated Kinetic Consequences Upon the Catalytic Cleft. Acs Medicinal Chemistry Letters. 4: 283-287. PMID 23565325 DOI: 10.1021/Ml300428S  1
2013 Lemichez E, Barbieri JT. General aspects and recent advances on bacterial protein toxins. Cold Spring Harbor Perspectives in Medicine. 3: a013573. PMID 23378599 DOI: 10.1101/cshperspect.a013573  1
2013 Barbieri JS, Weiss RL. Collapse of aortic tube graft during systole. Echocardiography (Mount Kisco, N.Y.). 30: E108-9. PMID 23228120 DOI: 10.1111/echo.12081  0.01
2013 Anstead M, Heltshe SL, Khan U, Barbieri JT, Langkamp M, Döring G, Dharia S, Gibson RL, Treggiari MM, Lymp J, Rosenfeld M, Ramsey B. Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trial. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 12: 147-53. PMID 22944725 DOI: 10.1016/J.Jcf.2012.08.001  1
2013 Simon NC, Vergis JM, Ebrahimi AV, Ventura CL, O'Brien AD, Barbieri JT. Host cell cytotoxicity and cytoskeleton disruption by CerADPr, an ADP-ribosyltransferase of Bacillus cereus G9241. Biochemistry. 52: 2309-18. PMID 22934824 DOI: 10.1021/Bi300692G  1
2012 Karalewitz AP, Fu Z, Baldwin MR, Kim JJ, Barbieri JT. Botulinum neurotoxin serotype C associates with dual ganglioside receptors to facilitate cell entry. The Journal of Biological Chemistry. 287: 40806-16. PMID 23027864 DOI: 10.1074/Jbc.M112.404244  1
2012 Karalewitz AP, Barbieri JT. Vaccines against botulism. Current Opinion in Microbiology. 15: 317-24. PMID 22694934 DOI: 10.1016/J.Mib.2012.05.009  1
2012 Chen S, Karalewitz AP, Barbieri JT. Insights into the different catalytic activities of Clostridium neurotoxins. Biochemistry. 51: 3941-7. PMID 22510015 DOI: 10.1021/Bi3000098  1
2012 Blum FC, Chen C, Kroken AR, Barbieri JT. Tetanus toxin and botulinum toxin a utilize unique mechanisms to enter neurons of the central nervous system. Infection and Immunity. 80: 1662-9. PMID 22392932 DOI: 10.1128/Iai.00057-12  1
2012 Barbieri J, Duboc H, Teillet F, Sabate JM, Peynaud E, Jouet P, Coffin B. Ischaemic colitis associated with JAK2V617F mutation. Gut. 61: 784-5. PMID 21742745 DOI: 10.1136/gutjnl-2011-300396  0.01
2012 Barbieri JT. Damage by microbial toxins Schaechter's Mechanisms of Microbial Disease: Fifth Edition. 127-139.  1
2011 Zhao J, Du Y, Horton JR, Upadhyay AK, Lou B, Bai Y, Zhang X, Du L, Li M, Wang B, Zhang L, Barbieri JT, Khuri FR, Cheng X, Fu H. Discovery and structural characterization of a small molecule 14-3-3 protein-protein interaction inhibitor. Proceedings of the National Academy of Sciences of the United States of America. 108: 16212-6. PMID 21908710 DOI: 10.1073/Pnas.1100012108  1
2011 Hritonenko V, Mun JJ, Tam C, Simon NC, Barbieri JT, Evans DJ, Fleiszig SM. Adenylate cyclase activity of Pseudomonas aeruginosa ExoY can mediate bleb-niche formation in epithelial cells and contributes to virulence. Microbial Pathogenesis. 51: 305-12. PMID 21843628 DOI: 10.1016/J.Micpath.2011.08.001  1
2011 Henkel JS, Tepp WH, Przedpelski A, Fritz RB, Johnson EA, Barbieri JT. Subunit vaccine efficacy against Botulinum neurotoxin subtypes. Vaccine. 29: 7688-95. PMID 21839134 DOI: 10.1016/J.Vaccine.2011.07.134  1
2011 Kroken AR, Karalewitz AP, Fu Z, Kim JJ, Barbieri JT. Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into neurons. The Journal of Biological Chemistry. 286: 26828-37. PMID 21632541 DOI: 10.1074/Jbc.M111.254086  1
2011 Kroken AR, Karalewitz AP, Fu Z, Baldwin MR, Kim JJ, Barbieri JT. Unique ganglioside binding by botulinum neurotoxins C and D-SA. The Febs Journal. 278: 4486-96. PMID 21554541 DOI: 10.1111/J.1742-4658.2011.08166.X  1
2011 Chen S, Barbieri JT. Association of botulinum neurotoxin serotype A light chain with plasma membrane-bound SNAP-25. The Journal of Biological Chemistry. 286: 15067-72. PMID 21378164 DOI: 10.1074/Jbc.M111.224493  1
2011 Pier CL, Chen C, Tepp WH, Lin G, Janda KD, Barbieri JT, Pellett S, Johnson EA. Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1. Febs Letters. 585: 199-206. PMID 21126520 DOI: 10.1016/J.Febslet.2010.11.045  1
2010 Eubanks LM, Silhár P, Salzameda NT, Zakhari JS, Xiaochuan F, Barbieri JT, Shoemaker CB, Hixon MS, Janda KD. Identification of a Natural Product Antagonist against the Botulinum Neurotoxin Light Chain Protease. Acs Medicinal Chemistry Letters. 1: 268-272. PMID 20959871 DOI: 10.1021/Ml100074S  1
2010 Angus AA, Evans DJ, Barbieri JT, Fleiszig SM. The ADP-ribosylation domain of Pseudomonas aeruginosa ExoS is required for membrane bleb niche formation and bacterial survival within epithelial cells. Infection and Immunity. 78: 4500-10. PMID 20732998 DOI: 10.1128/Iai.00417-10  1
2010 Karalewitz AP, Kroken AR, Fu Z, Baldwin MR, Kim JJ, Barbieri JT. Identification of a unique ganglioside binding loop within botulinum neurotoxins C and D-SA . Biochemistry. 49: 8117-26. PMID 20731382 DOI: 10.1021/Bi100865F  1
2010 Schmitt J, Karalewitz A, Benefield DA, Mushrush DJ, Pruitt RN, Spiller BW, Barbieri JT, Lacy DB. Structural analysis of botulinum neurotoxin type G receptor binding . Biochemistry. 49: 5200-5. PMID 20507178 DOI: 10.1021/Bi100412V  1
2010 Henkel JS, Baldwin MR, Barbieri JT. Toxins from bacteria. Exs. 100: 1-29. PMID 20358680 DOI: 10.1007/978-3-7643-8338-1_1  1
2010 Silhár P, Capková K, Salzameda NT, Barbieri JT, Hixon MS, Janda KD. Botulinum neurotoxin A protease: discovery of natural product exosite inhibitors. Journal of the American Chemical Society. 132: 2868-9. PMID 20158239 DOI: 10.1021/Ja910761Y  1
2010 Stowe GN, Silhár P, Hixon MS, Silvaggi NR, Allen KN, Moe ST, Jacobson AR, Barbieri JT, Janda KD. Chirality holds the key for potent inhibition of the botulinum neurotoxin serotype a protease. Organic Letters. 12: 756-9. PMID 20092262 DOI: 10.1021/Ol902820Z  1
2010 Capková K, Hixon MS, Pellett S, Barbieri JT, Johnson EA, Janda KD. Benzylidene cyclopentenediones: First irreversible inhibitors against botulinum neurotoxin A's zinc endopeptidase. Bioorganic & Medicinal Chemistry Letters. 20: 206-8. PMID 19914829 DOI: 10.1016/J.Bmcl.2009.10.129  1
2009 Salzameda NT, Barbieri JT, Janda KD. Synthetic substrate for application in both high and low throughput assays for botulinum neurotoxin B protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 19: 5848-50. PMID 19747823 DOI: 10.1016/J.Bmcl.2009.08.079  1
2009 Chen C, Fu Z, Kim JJ, Barbieri JT, Baldwin MR. Gangliosides as high affinity receptors for tetanus neurotoxin. The Journal of Biological Chemistry. 284: 26569-77. PMID 19602728 DOI: 10.1074/Jbc.M109.027391  1
2009 Rao AR, Laxova A, Farrell PM, Barbieri JT. Proteomic identification of OprL as a seromarker for initial diagnosis of Pseudomonas aeruginosa infection of patients with cystic fibrosis. Journal of Clinical Microbiology. 47: 2483-8. PMID 19553571 DOI: 10.1128/Jcm.02182-08  1
2009 Chen S, Barbieri JT. Engineering botulinum neurotoxin to extend therapeutic intervention. Proceedings of the National Academy of Sciences of the United States of America. 106: 9180-4. PMID 19487672 DOI: 10.1073/Pnas.0903111106  1
2009 Fu Z, Chen C, Barbieri JT, Kim JJ, Baldwin MR. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F. Biochemistry. 48: 5631-41. PMID 19476346 DOI: 10.1021/Bi9002138  1
2009 Baldwin MR, Barbieri JT. Association of botulinum neurotoxins with synaptic vesicle protein complexes. Toxicon : Official Journal of the International Society On Toxinology. 54: 570-4. PMID 19362106 DOI: 10.1016/j.toxicon.2009.01.040  1
2009 Henkel JS, Jacobson M, Tepp W, Pier C, Johnson EA, Barbieri JT. Catalytic properties of botulinum neurotoxin subtypes A3 and A4. Biochemistry. 48: 2522-8. PMID 19256469 DOI: 10.1021/Bi801686B  1
2008 Deng Q, Barbieri JT. Molecular mechanisms of the cytotoxicity of ADP-ribosylating toxins. Annual Review of Microbiology. 62: 271-88. PMID 18785839 DOI: 10.1146/Annurev.Micro.62.081307.162848  1
2008 Deng Q, Barbieri JT. Modulation of host cell endocytosis by the type III cytotoxin, Pseudomonas ExoS. Traffic (Copenhagen, Denmark). 9: 1948-57. PMID 18778330 DOI: 10.1111/J.1600-0854.2008.00808.X  1
2008 Chen C, Baldwin MR, Barbieri JT. Molecular basis for tetanus toxin coreceptor interactions. Biochemistry. 47: 7179-86. PMID 18543947 DOI: 10.1021/bi800640y  1
2008 Chen S, Hall C, Barbieri JT. Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin. The Journal of Biological Chemistry. 283: 21153-9. PMID 18511417 DOI: 10.1074/Jbc.M800611200  1
2008 Baldwin MR, Tepp WH, Przedpelski A, Pier CL, Bradshaw M, Johnson EA, Barbieri JT. Subunit vaccine against the seven serotypes of botulism. Infection and Immunity. 76: 1314-8. PMID 18070903 DOI: 10.1128/IAI.01025-07  1
2008 Pier CL, Tepp WH, Bradshaw M, Johnson EA, Barbieri JT, Baldwin MR. Recombinant holotoxoid vaccine against botulism. Infection and Immunity. 76: 437-42. PMID 17967862 DOI: 10.1128/IAI.00843-07  1
2007 Deng Q, Zhang Y, Barbieri JT. Intracellular trafficking of Pseudomonas ExoS, a type III cytotoxin. Traffic (Copenhagen, Denmark). 8: 1331-45. PMID 17714437 DOI: 10.1111/J.1600-0854.2007.00626.X  1
2007 Chen S, Barbieri JT. Multiple pocket recognition of SNAP25 by botulinum neurotoxin serotype E. The Journal of Biological Chemistry. 282: 25540-7. PMID 17609207 DOI: 10.1074/Jbc.M701922200  1
2007 Zhang Y, Deng Q, Porath JA, Williams CL, Pederson-Gulrud KJ, Barbieri JT. Plasma membrane localization affects the RhoGAP specificity of Pseudomonas ExoS. Cellular Microbiology. 9: 2192-201. PMID 17490406 DOI: 10.1111/J.1462-5822.2007.00949.X  1
2007 Zhang Y, Deng Q, Barbieri JT. Intracellular localization of type III-delivered Pseudomonas ExoS with endosome vesicles. The Journal of Biological Chemistry. 282: 13022-32. PMID 17311921 DOI: 10.1074/Jbc.M606305200  1
2007 Baldwin MR, Barbieri JT. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes. Biochemistry. 46: 3200-10. PMID 17311420 DOI: 10.1021/bi602396x  1
2007 Eubanks LM, Hixon MS, Jin W, Hong S, Clancy CM, Tepp WH, Baldwin MR, Malizio CJ, Goodnough MC, Barbieri JT, Johnson EA, Boger DL, Dickerson TJ, Janda KD. An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists. Proceedings of the National Academy of Sciences of the United States of America. 104: 2602-7. PMID 17293454 DOI: 10.1073/Pnas.0611213104  1
2007 Chen S, Kim JJ, Barbieri JT. Mechanism of substrate recognition by botulinum neurotoxin serotype A. The Journal of Biological Chemistry. 282: 9621-7. PMID 17244603 DOI: 10.1074/Jbc.M611211200  1
2007 Baldwin MR, Kim JJ, Barbieri JT. Botulinum neurotoxin B-host receptor recognition: it takes two receptors to tango. Nature Structural & Molecular Biology. 14: 9-10. PMID 17203068 DOI: 10.1038/Nsmb0107-9  1
2007 Maresso AW, Deng Q, Pereckas MS, Wakim BT, Barbieri JT. Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation. Cellular Microbiology. 9: 97-105. PMID 16889625 DOI: 10.1111/J.1462-5822.2006.00770.X  1
2006 Fu Z, Chen S, Baldwin MR, Boldt GE, Crawford A, Janda KD, Barbieri JT, Kim JJ. Light chain of botulinum neurotoxin serotype A: structural resolution of a catalytic intermediate. Biochemistry. 45: 8903-11. PMID 16846233 DOI: 10.1021/Bi060786Z  1
2006 Boldt GE, Kennedy JP, Hixon MS, McAllister LA, Barbieri JT, Tzipori S, Janda KD. Synthesis, characterization and development of a high-throughput methodology for the discovery of botulinum neurotoxin a inhibitors. Journal of Combinatorial Chemistry. 8: 513-21. PMID 16827563 DOI: 10.1021/Cc060010H  1
2006 Fang H, Luo W, Henkel J, Barbieri J, Green N. A yeast assay probes the interaction between botulinum neurotoxin serotype B and its SNARE substrate. Proceedings of the National Academy of Sciences of the United States of America. 103: 6958-63. PMID 16636286 DOI: 10.1073/Pnas.0510816103  1
2006 Chen S, Barbieri JT. Unique substrate recognition by botulinum neurotoxins serotypes A and E. The Journal of Biological Chemistry. 281: 10906-11. PMID 16478727 DOI: 10.1074/Jbc.M513032200  1
2006 Maresso AW, Frank DW, Barbieri JT. Pseudomonas aeruginosa toxins The Comprehensive Sourcebook of Bacterial Protein Toxins. 257-269. DOI: 10.1016/B978-012088445-2/50019-6  1
2005 Zhang Y, Barbieri JT. A leucine-rich motif targets Pseudomonas aeruginosa ExoS within mammalian cells. Infection and Immunity. 73: 7938-45. PMID 16299285 DOI: 10.1128/IAI.73.12.7938-7945.2005  1
2005 Baldwin MR, Tepp WH, Pier CL, Bradshaw M, Ho M, Wilson BA, Fritz RB, Johnson EA, Barbieri JT. Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E. Infection and Immunity. 73: 6998-7005. PMID 16177380 DOI: 10.1128/IAI.73.10.6998-7005.2005  1
2005 Deng Q, Sun J, Barbieri JT. Uncoupling Crk signal transduction by Pseudomonas exoenzyme T. The Journal of Biological Chemistry. 280: 35953-60. PMID 16123042 DOI: 10.1074/Jbc.M504901200  1
2005 Corech R, Rao A, Laxova A, Moss J, Rock MJ, Li Z, Kosorok MR, Splaingard ML, Farrell PM, Barbieri JT. Early immune response to the components of the type III system of Pseudomonas aeruginosa in children with cystic fibrosis. Journal of Clinical Microbiology. 43: 3956-62. PMID 16081936 DOI: 10.1128/Jcm.43.8.3956-3962.2005  1
2005 Baldwin MR, Barbieri JT. The type III cytotoxins of Yersinia and Pseudomonas aeruginosa that modulate the actin cytoskeleton. Current Topics in Microbiology and Immunology. 291: 147-66. PMID 15984080  1
2005 Aktories K, Barbieri JT. Bacterial cytotoxins: targeting eukaryotic switches. Nature Reviews. Microbiology. 3: 397-410. PMID 15821726 DOI: 10.1038/nrmicro1150  1
2005 Rao AR, Splaingard MS, Gershan WM, Havens PL, Thill A, Barbieri JT. Detection of Pseudomonas aeruginosa type III antibodies in children with tracheostomies. Pediatric Pulmonology. 39: 402-7. PMID 15666370 DOI: 10.1002/Ppul.20194  1
2004 Barbieri JT, Sun J. Pseudomonas aeruginosa ExoS and ExoT. Reviews of Physiology, Biochemistry and Pharmacology. 152: 79-92. PMID 15375697 DOI: 10.1007/S10254-004-0031-7  1
2004 Sun J, Maresso AW, Kim JJ, Barbieri JT. How bacterial ADP-ribosylating toxins recognize substrates. Nature Structural & Molecular Biology. 11: 868-76. PMID 15311272 DOI: 10.1038/Nsmb818  1
2004 Baldwin MR, Bradshaw M, Johnson EA, Barbieri JT. The C-terminus of botulinum neurotoxin type A light chain contributes to solubility, catalysis, and stability. Protein Expression and Purification. 37: 187-95. PMID 15294297 DOI: 10.1016/j.pep.2004.05.009  1
2004 Sun J, Barbieri JT. ExoS Rho GTPase-activating protein activity stimulates reorganization of the actin cytoskeleton through Rho GTPase guanine nucleotide disassociation inhibitor. The Journal of Biological Chemistry. 279: 42936-44. PMID 15292224 DOI: 10.1074/Jbc.M406493200  1
2004 Maresso AW, Baldwin MR, Barbieri JT. Ezrin/radixin/moesin proteins are high affinity targets for ADP-ribosylation by Pseudomonas aeruginosa ExoS. The Journal of Biological Chemistry. 279: 38402-8. PMID 15252013 DOI: 10.1074/Jbc.M405707200  1
2004 Krall R, Zhang Y, Barbieri JT. Intracellular membrane localization of pseudomonas ExoS and Yersinia YopE in mammalian cells. The Journal of Biological Chemistry. 279: 2747-53. PMID 14597627 DOI: 10.1074/jbc.M301963200  1
2003 Maresso AW, Riese MJ, Barbieri JT. Molecular heterogeneity of a type III cytotoxin, Pseudomonas aeruginosa exoenzyme S. Biochemistry. 42: 14249-57. PMID 14640693 DOI: 10.1021/Bi035053I  1
2003 Sun J, Barbieri JT. Pseudomonas aeruginosa ExoT ADP-ribosylates CT10 regulator of kinase (Crk) proteins. The Journal of Biological Chemistry. 278: 32794-800. PMID 12807879 DOI: 10.1074/Jbc.M304290200  1
2002 Maresso AW, Barbieri JT. Expression and purification of two recombinant forms of the type-III cytotoxin, Pseudomonas aeruginosa ExoS. Protein Expression and Purification. 26: 432-7. PMID 12460767 DOI: 10.1016/S1046-5928(02)00544-2  1
2002 Pederson KJ, Krall R, Riese MJ, Barbieri JT. Intracellular localization modulates targeting of ExoS, a type III cytotoxin, to eukaryotic signalling proteins. Molecular Microbiology. 46: 1381-90. PMID 12453223 DOI: 10.1046/J.1365-2958.2002.03256.X  1
2002 Barbieri JT, Riese MJ, Aktories K. Bacterial toxins that modify the actin cytoskeleton. Annual Review of Cell and Developmental Biology. 18: 315-44. PMID 12142277 DOI: 10.1146/Annurev.Cellbio.18.012502.134748  1
2002 Fraylick JE, Riese MJ, Vincent TS, Barbieri JT, Olson JC. ADP-ribosylation and functional effects of Pseudomonas exoenzyme S on cellular RalA. Biochemistry. 41: 9680-7. PMID 12135390 DOI: 10.1021/Bi025826N  1
2002 Riese MJ, Barbieri JT. Membrane localization contributes to the in vivo ADP-ribosylation of Ras by Pseudomonas aeruginosa ExoS. Infection and Immunity. 70: 2230-2. PMID 11895993 DOI: 10.1128/Iai.70.4.2230-2232.2002  1
2002 Riese MJ, Goehring UM, Ehrmantraut ME, Moss J, Barbieri JT, Aktories K, Schmidt G. Auto-ADP-ribosylation of Pseudomonas aeruginosa ExoS. The Journal of Biological Chemistry. 277: 12082-8. PMID 11821389 DOI: 10.1074/Jbc.M109039200  1
2002 Banwart B, Splaingard ML, Farrell PM, Rock MJ, Havens PL, Moss J, Ehrmantraut ME, Frank DW, Barbieri JT. Children with cystic fibrosis produce an immune response against exoenzyme S, a type III cytotoxin of Pseudomonas aeruginosa. The Journal of Infectious Diseases. 185: 269-70. PMID 11807706 DOI: 10.1086/338197  1
2002 Krall R, Sun J, Pederson KJ, Barbieri JT. In vivo rho GTPase-activating protein activity of Pseudomonas aeruginosa cytotoxin ExoS. Infection and Immunity. 70: 360-7. PMID 11748202 DOI: 10.1128/Iai.70.1.360-367.2002  1
2001 Masuda I, Iyama KI, Halligan BD, Barbieri JT, Haas AL, McCarty DJ, Ryan LM. Variations in site and levels of expression of chondrocyte nucleotide pyrophosphohydrolase with aging. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 16: 868-75. PMID 11341331 DOI: 10.1359/Jbmr.2001.16.5.868  1
2001 Riese MJ, Wittinghofer A, Barbieri JT. ADP ribosylation of Arg41 of Rap by ExoS inhibits the ability of Rap to interact with its guanine nucleotide exchange factor, C3G. Biochemistry. 40: 3289-94. PMID 11258948 DOI: 10.1021/Bi002729Q  1
2001 Würtele M, Renault L, Barbieri JT, Wittinghofer A, Wolf E. Structure of the ExoS GTPase activating domain. Febs Letters. 491: 26-9. PMID 11226412 DOI: 10.1016/S0014-5793(01)02105-6  1
2001 Moss J, Ehrmantraut ME, Banwart BD, Frank DW, Barbieri JT. Sera from adult patients with cystic fibrosis contain antibodies to Pseudomonas aeruginosa type III apparatus. Infection and Immunity. 69: 1185-8. PMID 11160019 DOI: 10.1128/Iai.69.2.1185-1188.2001  1
2001 Würtele M, Wolf E, Pederson KJ, Buchwald G, Ahmadian MR, Barbieri JT, Wittinghofer A. How the Pseudomonas aeruginosa ExoS toxin downregulates Rac. Nature Structural Biology. 8: 23-6. PMID 11135665 DOI: 10.1038/83007  1
2000 Barbieri JT. Pseudomonas aeruginosa exoenzyme S, a bifunctional type-III secreted cytotoxin. International Journal of Medical Microbiology : Ijmm. 290: 381-7. PMID 11111915 DOI: 10.1016/S1438-4221(00)80047-8  1
2000 Krall R, Schmidt G, Aktories K, Barbieri JT. Pseudomonas aeruginosa ExoT is a Rho GTPase-activating protein. Infection and Immunity. 68: 6066-8. PMID 10992524 DOI: 10.1128/IAI.68.10.6066-6068.2000  1
2000 Pederson KJ, Pal S, Vallis AJ, Frank DW, Barbieri JT. Intracellular localization and processing of Pseudomonas aeruginosa ExoS in eukaryotic cells. Molecular Microbiology. 37: 287-99. PMID 10931325 DOI: 10.1046/j.1365-2958.2000.01990.x  1
2000 Blöcker D, Barth H, Maier E, Benz R, Barbieri JT, Aktories K. The C terminus of component C2II of Clostridium botulinum C2 toxin is essential for receptor binding. Infection and Immunity. 68: 4566-73. PMID 10899856 DOI: 10.1128/IAI.68.8.4566-4573.2000  1
1999 Goehring UM, Schmidt G, Pederson KJ, Aktories K, Barbieri JT. The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases. The Journal of Biological Chemistry. 274: 36369-72. PMID 10593930 DOI: 10.1074/jbc.274.51.36369  1
1999 Zhang L, Wang H, Masters SC, Wang B, Barbieri JT, Fu H. Residues of 14-3-3 zeta required for activation of exoenzyme S of Pseudomonas aeruginosa. Biochemistry. 38: 12159-64. PMID 10508420 DOI: 10.1021/Bi991019L  1
1999 Ganesan AK, Vincent TS, Olson JC, Barbieri JT. Pseudomonas aeruginosa exoenzyme S disrupts Ras-mediated signal transduction by inhibiting guanine nucleotide exchange factor-catalyzed nucleotide exchange. The Journal of Biological Chemistry. 274: 21823-9. PMID 10419499 DOI: 10.1074/jbc.274.31.21823  1
1999 Knight DA, Barbieri JT. Expression of FAS-independent ADP-ribosyltransferase activity by a catalytic deletion peptide of Pseudomonas aeruginosa exoenzyme S. Biochemistry. 38: 5858-63. PMID 10231537 DOI: 10.1021/bi982133r  1
1999 Masters SC, Pederson KJ, Zhang L, Barbieri JT, Fu H. Interaction of 14-3-3 with a nonphosphorylated protein ligand, exoenzyme S of Pseudomonas aeruginosa. Biochemistry. 38: 5216-21. PMID 10213629 DOI: 10.1021/Bi982492M  1
1999 Ganesan AK, Mende-Mueller L, Selzer J, Barbieri JT. Pseudomonas aeruginosa exoenzyme S, a double ADP-ribosyltransferase, resembles vertebrate mono-ADP-ribosyltransferases. The Journal of Biological Chemistry. 274: 9503-8. PMID 10092634 DOI: 10.1074/jbc.274.14.9503  1
1999 Radke J, Pederson KJ, Barbieri JT. Pseudomonas aeruginosa exoenzyme S is a biglutamic acid ADP-ribosyltransferase. Infection and Immunity. 67: 1508-10. PMID 10024602  1
1999 Vallis AJ, Yahr TL, Barbieri JT, Frank DW. Regulation of ExoS production and secretion by Pseudomonas aeruginosa in response to tissue culture conditions. Infection and Immunity. 67: 914-20. PMID 9916108 DOI: 10.1128/Iai.67.2.914-920.1999  1
1998 Pederson KJ, Barbieri JT. Intracellular expression of the ADP-ribosyltransferase domain of Pseudomonas exoenzyme S is cytotoxic to eukaryotic cells. Molecular Microbiology. 30: 751-9. PMID 10094623 DOI: 10.1046/j.1365-2958.1998.01106.x  1
1998 Yahr TL, Vallis AJ, Hancock MK, Barbieri JT, Frank DW. ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. Proceedings of the National Academy of Sciences of the United States of America. 95: 13899-904. PMID 9811898 DOI: 10.1073/Pnas.95.23.13899  1
1998 Truitt RL, Hanke C, Radke J, Mueller R, Barbieri JT. Glycosphingolipids as Novel Targets for T-Cell Suppression by the B Subunit of Recombinant Heat-Labile Enterotoxin Infection and Immunity. 66: 1299-1308. PMID 9529046 DOI: 10.1128/Iai.66.4.1299-1308.1998  1
1998 Ganesan AK, Frank DW, Misra RP, Schmidt G, Barbieri JT. Pseudomonas aeruginosa exoenzyme S ADP-ribosylates Ras at multiple sites. The Journal of Biological Chemistry. 273: 7332-7. PMID 9516428 DOI: 10.1074/jbc.273.13.7332  1
1997 Masuda I, Halligan BD, Barbieri JT, Haas AL, Ryan LM, McCarty DJ. Molecular cloning and expression of a porcine chondrocyte nucleotide pyrophosphohydrolase. Gene. 197: 277-87. PMID 9332376 DOI: 10.1016/S0378-1119(97)00272-2  1
1997 Kntght DA, Barbieri JT. Ecto-ADP-ribosyltransferase activity of Pseudomonas aeruginosa exoenzyme S Infection and Immunity. 65: 3304-3309. PMID 9234791  1
1997 Liu S, Yahr TL, Frank DW, Barbieri JT. Biochemical relationships between the 53-kilodalton (Exo53) and 49-kilodalton (ExoS) forms of exoenzyme S of Pseudomonas aeruginosa. Journal of Bacteriology. 179: 1609-13. PMID 9045820 DOI: 10.1128/Jb.179.5.1609-1613.1997  1
1996 Finck-Barbançon V, Barbieri JT. Preferential processing of the S1 subunit of pertussis toxin that is bound to eukaryotic cells Molecular Microbiology. 22: 87-95. PMID 8899711 DOI: 10.1111/j.1365-2958.1996.tb02658.x  1
1996 Yahr TL, Barbieri JT, Frank DW. Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa. Journal of Bacteriology. 178: 1412-9. PMID 8631719 DOI: 10.1128/Jb.178.5.1412-1419.1996  1
1996 Liu S, Kulich SM, Barbieri JT. Identification of glutamic acid 381 as a candidate active site residue of Pseudomonas aeruginosa exoenzyme S. Biochemistry. 35: 2754-8. PMID 8611582 DOI: 10.1021/bi952340g  1
1996 Xu Y, Barbieri JT. Pertussis toxin-catalyzed ADP-ribosylation of Gi-2 and Gi-3 in CHO cells is modulated by inhibitors of intracellular trafficking Infection and Immunity. 64: 593-599. PMID 8550212  1
1995 Xu Y, Barbieri JT. Pertussis toxin-mediated ADP-ribosylation of target proteins in Chinese hamster ovary cells involves a vesicle trafficking mechanism Infection and Immunity. 63: 825-832. PMID 7868253  1
1995 Finck-Barbancon V, Barbieri JT. ADP-ribosylation of α(i3)C20 by the S1 subunit and deletion peptides of S1 of pertussis toxin Biochemistry. 34: 1070-1075. PMID 7827022 DOI: 10.1021/bi00003a043  1
1995 Kulich SM, Frank DW, Barbieri JT. Expression of recombinant exoenzyme S of Pseudomonas aeruginosa. Infection and Immunity. 63: 1-8. PMID 7806344  1
1995 Krueger KM, Barbieri JT. The family of bacterial ADP-ribosylating exotoxins. Clinical Microbiology Reviews. 8: 34-47. PMID 7704894  1
1995 Knight DA, Finck-Barbançon V, Kulich SM, Barbieri JT. Functional domains of Pseudomonas aeruginosa exoenzyme S. Infection and Immunity. 63: 3182-6. PMID 7622246  1
1994 Xu Y, Barbieri JT. Biochemical analysis of mutations at tyrosine-98 of the SI subunit of pertussis toxin Biochemistry. 33: 1573-1579. PMID 8312278  1
1994 Krueger KM, Barbieri JT. Assignment of functional domains involved in ADP-ribosylation and B-oligomer binding within the carboxyl terminus of the S1 subunit of pertussis toxin. Infection and Immunity. 62: 2071-8. PMID 8168972  1
1994 Xu Y, Barbançon-Finck V, Barbieri JT. Role of histidine 35 of the S1 subunit of pertussis toxin in the ADP-ribosylation of transducin Journal of Biological Chemistry. 269: 9993-9999. PMID 8144593  1
1993 Krueger KM, Barbieri JT. Molecular characterization of the in vitro activation of pertussis toxin by ATP. The Journal of Biological Chemistry. 268: 12570-8. PMID 8509398  1
1993 Kulich SM, Frank DW, Barbieri JT. Purification and characterization of exoenzyme S from Pseudomonas aeruginosa 388. Infection and Immunity. 61: 307-13. PMID 8418052  1
1992 Barbieri JT, Armellini D, Molkentin J, Rappuoli R. Construction of a diphtheria toxin A fragment-C180 peptide fusion protein which elicits a neutralizing antibody response against diphtheria toxin and pertussis toxin Infection and Immunity. 60: 5071-5077. PMID 1452339 DOI: 10.1128/Iai.60.12.5071-5077.1992  1
1992 Sandbaken MG, Runquist JA, Barbieri JT, Miziorko HM. Identification of the phosphoribulokinase sugar phosphate binding domain Biochemistry®. 31: 3715-3719. PMID 1314650 DOI: 10.1021/Bi00129A022  1
1991 Cortina G, Barbieri JT. Localization of a region of the S1 subunit of pertussis toxin required for efficient ADP-ribosyltransferase activity Journal of Biological Chemistry. 266: 3022-3030. PMID 1993675  1
1991 Krueger KM, Mende-Mueller LM, Barbieri JT. Protease treatment of pertussis toxin identifies the preferential cleavage of the S1 subunit. The Journal of Biological Chemistry. 266: 8122-8. PMID 1850738  1
1991 Cortina G, Krueger KM, Barbieri JT. The carboxyl terminus of the S1 subunit of pertussis toxin confers high affinity binding to transducin. The Journal of Biological Chemistry. 266: 23810-4. PMID 1748655  1
1990 Barbieri JT, Pizza M, Cortina G, Rappuoli R. Biochemical and biological activities of recombinant S1 subunit of pertussis toxin Infection and Immunity. 58: 999-1003. PMID 2108094  1
1989 Barbieri JT, Mende-Mueller LM, Rappuoli R, Collier RJ. Photolabeling of Glu-129 of the S-1 subunit of pertussis toxin with NAD. Infection and Immunity. 57: 3549-54. PMID 2807535 DOI: 10.1128/Iai.57.11.3549-3554.1989  1
1989 Cortina G, Barbieri JT. Role of tryptophan 26 in the NAD glycohydrolase reaction of the S-1 subunit of pertussis toxin Journal of Biological Chemistry. 264: 17322-17328. PMID 2551899  1
1989 Barbieri JT, Moloney BK, Mende-Mueller LM. Expression and secretion of the S-1 subunit and C180 peptide of pertussis toxin in Escherichia coli Journal of Bacteriology. 171: 4362-4369. PMID 2546919  1
1988 Carroll SF, Barbieri JT, Collier RJ. Diphtheria toxin: purification and properties. Methods in Enzymology. 165: 68-76. PMID 3148099 DOI: 10.1016/S0076-6879(88)65014-2  1
1988 Barbieri JT, Cortina G. ADP-ribosyltransferase mutations in the catalytic S-1 subunit of pertussis toxin Infection and Immunity. 56: 1934-1941. PMID 3135265  1
1987 Barbieri JT, Collier RJ. Expression of a mutant, full-length form of diphtheria toxin in Escherichia coli Infection and Immunity. 55: 1647-1651. PMID 3110068 DOI: 10.1128/Iai.55.7.1647-1651.1987  1
1987 Barbieri JT, Rappuoli R, Collier RJ. Expression of the S-1 catalytic subunit of pertussis toxin in Escherichia coli Infection and Immunity. 55: 1321-1323. PMID 2883125 DOI: 10.1128/Iai.55.5.1321-1323.1987  1
1986 Barbieri JT, Collins CM, Collier RJ. Diphtheria toxin can simultaneously bind to its receptor and adenylyl-(3′,5′)-uridine 3′-monophosphate Biochemistry. 25: 6608-6611. PMID 3790545 DOI: 10.1021/Bi00369A041  1
1985 Tweten RK, Barbieri JT, Collier RJ. Diphtheria toxin. Effect of substituting aspartic acid for glutamic acid 148 on ADP-ribosyltransferase activity. The Journal of Biological Chemistry. 260: 10392-4. PMID 2863266  1
1985 Fedde K, Barbieri J, Collier RJ, Sly WS. Intracellular transport and processing of diptheria toxin (DT) in BSC-1 cells Federation Proceedings. 44: 6123.  1
1984 Collins CM, Barbieri JT, Collier RJ. Interaction of diphtheria toxin with adenylyl-(3',5')-uridine 3'-monophosphate. I. Equilibrium and kinetic measurements Journal of Biological Chemistry. 259: 15154-15158. PMID 6511788  1
1981 Barbieri JT, Carroll SF, Collier RJ, McCloskey JA. An endogenous dinucleotide bound to diphtheria toxin. Adenylyl-(3',5')-uridine 3'-monophosphate Journal of Biological Chemistry. 256: 12247-12251. PMID 7298656  1
1981 Austin FE, Barbieri JT, Corin RE, Grigas KE, Cox CD. Distribution of superoxide dismutase, catalase, and peroxidase activities among Treponema pallidum and other spirochetes. Infection and Immunity. 33: 372-9. PMID 7024127  1
1981 Barbieri JT, Cox CD. Influence of oxygen on respiration and glucose catabolism by Treponema pallidum. Infection and Immunity. 31: 992-7. PMID 7014470  1
1981 Barbieri JT, Austin FE, Cox CD. Distribution of glucose incorporated into macromolecular material by treponema pallidum. Infection and Immunity. 31: 1071-7. PMID 7014454  1
1979 Barbieri JT, Cox CD. Pyruvate oxidation by Treponema pallidum. Infection and Immunity. 25: 157-63. PMID 383612  1
1979 Barbieri JT, Cox CD. Glucose incorporation by Treponema pallidum. Infection and Immunity. 24: 291-3. PMID 378845  1
Show low-probability matches.